1887
Volume 2014, Issue 1
  • ISSN: 2220-2749
  • E-ISSN:

Abstract

Current clinical recommendations for patients with stable coronary artery disease (CAD) and those post-acute coronary syndromes (ACS) suggest initiation of patients on dual antiplatelet therapy, an angiotensin-converting enzyme (ACE) inhibitor, a beta-blocker and an HMG-CoA reductase inhibitor prior to hospital discharge. Commonly, this drug regimen is continued indefinitely. More recently, however, emerging evidence suggests that long-term therapy with beta-blockers may in fact be of no benefit to patients with stable CAD. This evidence-based review will summarize the current practice recommendations, as well as provide a critical analysis of available literature regarding beta-blockers in stable CAD. Both efficacy and safety will be considered and implications for current clinical practice will be discussed.

Loading

Article metrics loading...

/content/journals/10.5339/avi.2014.4
2015-02-01
2019-08-18
Loading full text...

Full text loading...

/deliver/fulltext/avi/2014/1/avi.2014.4.html?itemId=/content/journals/10.5339/avi.2014.4&mimeType=html&fmt=ahah

References

  1. [1]. Bangalore   S., , Steg   PG., , Deedwania   P., , Crowley   K., , Eagle   KA., , Goto   S., , Magnus Ohman   E., , Cannon   CP., , Smith   SC., , Zeymer   U., , Hoffman   EB., , Messerli   FH., , Bhatt   DL. . β-Blocker Use and Clinical Outcomes in Stable Outpatients With and Without Coronary Artery Disease. . JAMA . 2012; ;308: 13 : 1340– 1349 .
    [Google Scholar]
  2. [2]. First International Study of Infarct Survival Collaborative Group . Randomised trial of intravenous atenolol among 16 027 cases of suspected acute myocardial infarction: ISIS-1. . Lancet . 1986; ;2: 8498 : 57– 66 .
    [Google Scholar]
  3. [3]. The MIAMI Trial Research Group . Metoprolol in acute myocardial infarction (MIAMI). A randomized placebo-controlled international trial. . Eur Heart J . 1985; ;6: 3 : 199– 226 .
    [Google Scholar]
  4. [4]. Clopidogrel and Metoprolol in Myocardial Infarction Trial collaborative group . Early intravenous then oral metoprolol in 45 852 patients with acute myocardial infarction: randomized placebo-controlled trial. . Lancet . 2005; ;366: : 1622– 1632 .
    [Google Scholar]
  5. [5]. Smith   SC., , Benjamin   EJ., , Bonow   RO., , Braun   LT., , Creager   MA., , Franklin   BA., , Gibbons   RJ., , Grundy   SM., , Hiratzka   LF., , Jones   DW., , Lloyd-Jones   DM., , Minissian   M., , Mosca   L., , Peterson   ED., , Sacco   RL., , Spertus   J., , Stein   JH., , Taubert   KA. . AHA/ACCF Secondary Prevention and Risk Reduction Therapy for Patients With Coronary and Other Atherosclerotic Vascular Disease: Update: A Guideline From the American Heart Association and American College of Cardiology Foundation. . Circulation . 2011; ;124: : 2458– 2473 .
    [Google Scholar]
  6. [6]. The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC) . ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. . Eur Heart J . 2011; ;32: : 2999– 3054 .
    [Google Scholar]
  7. [7]. Freemantle   N., , Cleland   J., , Young   P., , Mason   J., , Harrison   J. . β-Blockade after myocardial infarction: systematic review and meta regression analysis. . BMJ . 1999; ;318: : 1730– 1737 .
    [Google Scholar]
  8. [8]. Pepine   CJ., , Cohn   PF., , Deedwania   PC., , Gibson   RS., , Handberg   E., , Hill   JA., , Miller   E., , Marks   RG., , Thadani   U. . Effects of treatment on outcome in mildly symptomatic patients with ischemia during daily life. The Atenolol Silent Ischemia Study (ASIST). . Circulation . 1994; ;90: : 762– 768 .
    [Google Scholar]
  9. [9]. Kohro   T., , Hayashi   D., , Yamazaki   T., , Nagai   R. . Beta-Blocker Prescription Among Japanese Cardiologists and Its Effect on Various Outcomes. . Circ J . 2010; ;74: : 962– 969 .
    [Google Scholar]
  10. [10]. Gottlieb   SS., , McCarter   RJ., , Vogel   RA. . Effect of beta-blockade on mortality among high-risk and low-risk patients after myocardial infarction. . N Engl J Med . 1998; ;339: : 489– 497 .
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journals/10.5339/avi.2014.4
Loading
/content/journals/10.5339/avi.2014.4
Loading

Data & Media loading...

  • Article Type: Research Article
Keyword(s): beta-blocker , coronary artery disease and evidence based medicine
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error